investment

News

AZ deepens Chinese ties, signs $18.5bn CSPC obesity deal

AstraZeneca deepens ties with China, pledging $15bn in investment and signing a big $18.5bn alliance with CSPC Pharma for obesity and diabetes drugs.

News

AbbVie turbocharges its US investment promise to $100bn

AbbVie finally agrees a Most-Favoured Nation pricing deal with the US administration, with a $100 billion investment promise attached.

News

J&J jumps on the MFN pricing train

Johnson & Johnson is the latest pharma group to agree a Most-Favoured Nation (MFN) drug pricing deal with the Trump administration to avert tariffs.

Sales & Marketing

Discussion in an HCP office about possibilities

HSA growth and the opportunities emerging for investors and ...

Paying attention to the intersection of public policy and business opportunity can be a winning strategy for start-ups and disrupters.

Market Access

Why the NHS remains the world's most challenging – and rewar...

For pharmaceutical, biotech, and medtech companies eyeing global expansion, the NHS presents a paradox.

News

Medicxi raises €500m for latest biotech fund

Medicxi closes its fifth round, raising €500m for 'asset-centric' firms at all stages of development and taking the total raised in 10 years to €2bn+.

AZ deepens Chinese ties, signs $18.5bn CSPC obesity deal

AbbVie turbocharges its US investment promise to $100bn

J&J jumps on the MFN pricing train

HSA growth and the opportunities emerging for investors and ...

Why the NHS remains the world's most challenging – and rewar...

Medicxi raises €500m for latest biotech fund

Allogeneic cell therapy isn’t dead, with Brian Culley

How to meet your physicians where they are online

investment

Editor's Picks